Department of Clinical Science, University of Bergen, Bergen, Norway.
Department of Paediatrics and Adolescence Medicine, Haukeland University Hospital, Bergen, Norway.
Pharmacoepidemiol Drug Saf. 2022 Jul;31(7):749-757. doi: 10.1002/pds.5438. Epub 2022 Apr 19.
To investigate ambulatory antibiotic use in children during 1 year before and 1 year after in-hospital antibiotic exposure compared to children from the general population that had not received antibiotics in-hospital.
Explorative data-linkage cohort study from Norway of children aged 3 months to 17 years. One group had received antibiotics in-Hospital (H+), and one group had not received antibiotics in-hospital (H-). The H+ group was recruited during admission in 2017. Using the Norwegian Population Registry, 10 children from the H- group were matched with one child from the H+ group according to county of residence, age and sex. We used the Norwegian Prescription Database to register antibiotic use 1 year before and 1 year after the month of hospitalisation.
Of 187 children in the H+ group, 83 (44%) received antibiotics before hospitalisation compared to 288/1870 (15%) in the H- group, relative risk (RR) 2.88 (95% confidence interval 2.38-3.49). After hospitalisation, 86 (46%) received antibiotics in the H+ group compared to 311 (17%) in the H- group, RR 2.77 (2.30-3.33). Comorbidity-adjusted RR was 2.30 (1.84-2.86) before and 2.25 (1.81-2.79) after hospitalisation. RR after hospitalisation was 2.55 (1.99-3.26) in children 3 months-2 years, 4.03 (2.84-5.71) in children 3-12 years and 2.07 (1.33-3.20) in children 13-17 years.
Children exposed to antibiotics in-hospital had two to three times higher risk of receiving antibiotics in ambulatory care both before and after hospitalisation. The link between in-hospital and ambulatory antibiotic exposure should be emphasised in future antibiotic stewardship programs.
调查与未住院使用抗生素的普通人群儿童相比,住院期间使用抗生素 1 年后和 1 年前门诊抗生素使用情况。
这是一项来自挪威的探索性数据链接队列研究,纳入了 3 个月至 17 岁的儿童。一组儿童住院期间接受过抗生素治疗(H+),另一组儿童未住院接受过抗生素治疗(H-)。H+组在 2017 年住院期间招募。利用挪威人口登记处,根据居住县、年龄和性别,从 H-组中匹配 10 名儿童与 H+组中的一名儿童。我们利用挪威处方数据库登记了住院前 1 年和住院后 1 年的抗生素使用情况。
H+组 187 名儿童中,83 名(44%)在住院前接受过抗生素治疗,而 H-组 1870 名儿童中,288 名(15%)接受过抗生素治疗,相对风险(RR)为 2.88(95%置信区间 2.38-3.49)。住院后,H+组 86 名(46%)儿童接受了抗生素治疗,而 H-组 311 名(17%)儿童接受了抗生素治疗,RR 为 2.77(2.30-3.33)。调整合并症后的 RR 分别为住院前 2.30(1.84-2.86)和住院后 2.25(1.81-2.79)。住院后,3 个月至 2 岁儿童 RR 为 2.55(1.99-3.26),3 至 12 岁儿童 RR 为 4.03(2.84-5.71),13-17 岁儿童 RR 为 2.07(1.33-3.20)。
住院期间接受抗生素治疗的儿童在门诊接受抗生素治疗的风险比普通人群儿童高 2 至 3 倍,无论是住院前还是住院后。在未来的抗生素管理项目中,应强调住院与门诊抗生素暴露之间的联系。